facebook twitter linkedin
  • images/stories/slider.png
  • images/stories/slider2.png
  • images/stories/slider3.png
  • images/stories/slider4.png

NEWS RELEASES

  • Selvita shows strong revenue growth in the first quarter of 2015

    Krakow, 12 May 2015 - Selvita, the largest drug discovery company in Central and Eastern Europe, generated a net profit of PLN 1.3 MM in the first quarter of 2015, which marks 119% increase as compared to Q1 2014. EBITDA reached value of PLN 1.9 MM,…

    Read More...

  • Selvita receives the Economic Award of the President of Poland

    Krakow, 07 May 2015 - Selvita, a global drug discovery company engaged in the development of breakthrough oncology treatments and drug discovery services, was awarded the Economic Award of the President of Poland in the category Innovation.   The a…

    Read More...

  • Selvita initiates IND-enabling Studies for its first-in-class PIM/FLT3 inhibitor

    Krakow, 31 March 2015 - Selvita (WSE:SLV), the largest drug discovery company in Central and Eastern Europe, announced today that it is commencing IND-enabling studies for SEL24 project, the company’s first oncology drug candidate. &n SEL24 is a nov…

    Read More...